ASPIRIN - A WONDER
| dc.contributor.author | Hafizullah, Mohammad | |
| dc.contributor.author | Hafiz, Shazia | |
| dc.date.accessioned | 2026-09-05T09:29:27Z | |
| dc.date.issued | 2014-05-15 | |
| dc.description.abstract | ABSTRACT: Aspirin is in use since 1758. Aspirin has got beneficial anti inflammatory and anti thrombotic effect (inhibition of thromboxane A2). There is a rich data to support its use in acute coronary syndrome and secondary prevention of cardiovascular events. Most studies have shown the side effects of Aspirin as GI upset and bleeding. The exact role of Aspirin in primary prevention awaits further studies currently under process. The biggest challenge that faces the medical community is to identify patients who will derive the greatest benefits yet minimal harm ful side effects. | |
| dc.identifier.citation | Pakistan Heart Journal; Vol. 46 No. 4 (2013) | |
| dc.identifier.doi | 10.47144/phj.v46i4.700 | |
| dc.identifier.uri | https://pakheartjournal.com/index.php/pk/article/view/700 | |
| dc.identifier.uri | https://ds.pakheartjournal.com/handle/phj/1391 | |
| dc.language.iso | en | |
| dc.publisher | Pakistan Cardiac Society | |
| dc.relation.ispartofseries | Pakistan Heart Journal; Vol. 46 No. 4 (2013) | |
| dc.subject | ACS | |
| dc.subject | Aspirin | |
| dc.subject | Aspirin Resistence | |
| dc.subject | Cardiovascular Disease | |
| dc.subject | Prevention | |
| dc.subject | Stroke | |
| dc.title | ASPIRIN - A WONDER | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 700-1-1367-1-10-20140203.pdf
- Size:
- 686.14 KB
- Format:
- Adobe Portable Document Format